NewAmsterdam Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAMS and other ETFs, options, and stocks.About NAMS
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol.
CEOMichael H. Davidson
CEOMichael H. Davidson
Employees68
Employees68
HeadquartersNaarden, Noord-Holland
HeadquartersNaarden, Noord-Holland
Founded2022
Founded2022
Employees68
Employees68
NAMS Key Statistics
Market cap4.00B
Market cap4.00B
Price-Earnings ratio-17.27
Price-Earnings ratio-17.27
Dividend yield—
Dividend yield—
Average volume1.13M
Average volume1.13M
High today$36.49
High today$36.49
Low today$34.70
Low today$34.70
Open price$35.88
Open price$35.88
Volume1.21M
Volume1.21M
52 Week high$42.00
52 Week high$42.00
52 Week low$14.06
52 Week low$14.06
Stock Snapshot
With a market cap of 4B, NewAmsterdam Pharma(NAMS) trades at $35.00. The stock has a price-to-earnings ratio of -17.27.
During the trading session on 2025-12-07, NewAmsterdam Pharma(NAMS) shares reached a daily high of $36.49 and a low of $34.70. At a current price of $35.00, the stock is +0.9% higher than the low and still -4.1% under the high.
Trading volume for NewAmsterdam Pharma(NAMS) stock has reached 1.21M, versus its average volume of 1.13M.
The stock's 52-week range extends from a low of $14.06 to a high of $42.00.
The stock's 52-week range extends from a low of $14.06 to a high of $42.00.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
People also own
Based on the portfolios of people who own NAMS. This list is generated using Robinhood data, and it’s not a recommendation.